ROSAVE F 10 (Fenofibrate (160mg) + Rosuvastatin (10mg) )

Rosave F 10 Tablet is a formulation that incorporates two medications aimed at reducing lipid levels in the bloodstream. It is primarily prescribed to manage elevated cholesterol and triglycerides when dietary modifications alone, such as adhering to a low-fat regimen, have proven insufficient. This treatment is essential for minimizing the likelihood of cardiovascular events, including heart disease. Patients may administer this medication either with food or on an empty stomach, but it is advisable to take it at the same hour each day to establish a consistent routine. The prescribing physician will determine the appropriate dosage based on individual lipid levels and the patient’s response to the treatment. It is crucial to understand that individuals with high cholesterol and triglycerides may not experience any overt symptoms; however, discontinuing the medication can lead to heightened lipid levels, exacerbating the condition and heightening the risk of heart disease and stroke. Regular monitoring of lipid profiles is vital while using this medication. Additionally, this treatment should be seen as part of a comprehensive health program that includes a balanced low-fat diet, consistent physical activity, avoidance of smoking, moderation in alcohol consumption, and weight management. While on this treatment, patients can maintain a normal diet, though it is recommended to limit the intake of fatty foods. Common mild side effects include nausea, abdominal discomfort, constipation, headaches, flatulence, and muscle discomfort. If any of these effects persist or if symptoms such as yellowing of the skin or eyes, unusual bruising, or severe unexplained muscle aches occur, it is essential to seek medical advice. Periodic liver function tests may also be suggested by your healthcare provider during treatment. This medication should be avoided in individuals with liver disorders, particularly those presenting abnormal liver function test results or jaundice. Patients with kidney concerns or who are pregnant, planning to conceive, or breastfeeding should inform their healthcare provider before commencing treatment, as diabetic individuals should closely monitor their blood glucose levels during therapy, given that it may lead to elevated glucose levels.